뇌진탕 시장 보고서(2025년)
Concussion Global Market Report 2025
상품코드 : 1824363
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,661,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,629,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,596,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

뇌진탕 시장 규모는 향후 수년간 안정된 성장이 전망됩니다. 2029년에는 CAGR 4.8%를 나타내 99억 달러로 성장할 것으로 예상됩니다. 예측 기간의 성장은 스포츠의 안전성에 대한 지속적인 주목, 치료에 있어서의 연구개발, 뇌진탕 프로토콜의 채용 증가, 공중위생에 대한 관심의 높아짐, 의료계와 스포츠계의 제휴 등에 기인하는 것으로 예측됩니다. 예측 기간 중 주요 동향으로는 원격 뇌진탕 서비스와 원격 모니터링, 뇌진탕 예방을 위한 교육 이니셔티브, 장기적 영향과 만성 외상성 뇌증(CTE)에 관한 연구, 스포츠 조직에 뇌진탕 프로토콜 도입, 신경보호 요법 개발, 뇌진탕 관리를 위한 법규제 등이 있습니다.

향후 5년간의 성장률 4.8%라고 하는 예측은 전회의 예측으로부터 0.2%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 장벽은 스웨덴과 네덜란드에서 공급되는 고급 뇌진탕 평가 장비의 비용을 높이고 정확한 진단을 늦추고 신경과의 비용을 높여 미국 시장을 방해할 것으로 예측됩니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위하게 됩니다.

뇌진탕 시장 성장은 뇌 손상의 유병률 증가에 의해 촉진될 것으로 예측됩니다. 뇌 손상은 뇌에 영향을 미치는 다양한 손상을 포함하며, 그 결과 신체적, 인지적, 감정적으로 다양한 장애가 발생합니다. 뇌진탕의 적시 및 적절한 치료는 뇌 관련 손상으로 인한 뇌의 전체 건강에 미치는 영향을 줄이기 위해 매우 중요합니다. 이를 위해서는 신체적·인지적 안정, 증상 관리, 활동으로의 단계적 복귀 등의 실천이 필요합니다. 교통사고 증가도 뇌손상 발생률을 높이고 있습니다. 미국 미생물공학정보센터(NCBI)의 2023년 1월 기사에 따르면 미국에서는 연간 추정 170만명이 외상성 뇌 손상을 경험하고 있으며, 15-19세와 65세 이상의 노인이 가장 높은 위험에 직면하고 있습니다. 또한 미국에서는 뇌와 척수의 원발성 악성 종양이 수천 명에 영향을 미칠 것으로 예측됩니다. 그 결과, 뇌손상 유병률 증가가 뇌진탕 시장의 주요 촉진요인이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

A concussion refers to a form of traumatic brain injury (TBI) resulting from a sudden impact or force to the head or body, leading to the rapid movement of the brain within the skull. This condition can cause temporary impairment of brain function and disrupt normal neurological activities.

Concussion assessments primarily revolve around diagnosis and treatment. Diagnosis involves identifying the medical condition or injury through a comprehensive assessment of symptoms, medical history, and various diagnostic tests. These tests often include imaging tools such as magnetic resonance imaging (MRI), X-rays, computed tomography (CT), as well as monitoring devices and other diagnostic equipment. These assessments are utilized by a range of healthcare facilities such as hospitals, clinics, diagnostic centers, and medical camps to evaluate and manage concussions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The concussion market research report is one of a series of new reports from The Business Research Company that provides concussion market statistics, including the concussion industry's global market size, regional shares, competitors with a concussion market share, detailed concussion market segments, market trends and opportunities, and any further data you may need to thrive in the concussion industry. This concussion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The concussion market size has grown steadily in recent years. It will grow from $7.97 billion in 2024 to $8.2 billion in 2025 at a compound annual growth rate (CAGR) of 2.9%. The growth in the historic period can be attributed to increased awareness and education, sports participation and injuries, stringent sports regulations, advancements in diagnostic tools, and legal and ethical implications.

The concussion market size is expected to see steady growth in the next few years. It will grow to $9.9 billion in 2029 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to the continued focus on sports safety, research and development in treatment, increased adoption of concussion protocols, growing public health concerns, and collaboration between medical and sports communities. Major trends in the forecast period include teleconcussion services and remote monitoring, educational initiatives for concussion prevention, research on long-term effects and chronic traumatic encephalopathy (CTE), implementation of concussion protocols in sports organizations, development of neuroprotective therapies, legislation, and regulations for concussion management.

The forecast of 4.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of advanced concussion assessment devices sourced from Sweden and the Netherlands, thereby delaying accurate diagnoses and elevating neurology department costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the concussion market is anticipated to be propelled by an increase in the prevalence of brain injuries. Brain injuries encompass a range of damages affecting the brain, resulting in diverse physical, cognitive, and emotional impairments. Timely and appropriate treatment of concussions is crucial for mitigating the impact of brain-related injuries on overall brain health. This involves practices such as physical and cognitive rest, symptom management, and a gradual return to activities. The escalation in traffic accidents has also contributed to the higher incidence of brain injuries. According to a January 2023 article from the National Center for Biotechnology Information (NCBI), an estimated 1.7 million people in the United States experience traumatic brain injuries annually, with individuals aged 15 to 19 and seniors aged 65 and older facing the highest risk. Moreover, primary malignant tumors of the brain and spinal cord are expected to impact thousands of people in the US. Consequently, the increasing prevalence of brain injuries is a key driver of the concussion market.

The growth trajectory of the concussion market is further expected to be influenced by the rise in the prevalence of neurological diseases. Neurological diseases constitute a diverse range of medical conditions affecting the nervous system, encompassing the brain, spinal cord, and peripheral nerves. Traumatic brain injuries, often involving concussions, are significant contributors to the initiation, exacerbation, or complications of various neurological diseases such as chronic traumatic encephalopathy (CTE) or post-concussion syndrome. As of February 2023, the World Health Organization (WHO) reports that epilepsy, a neurological disease, affects approximately 5 million people globally. High-income countries witness 49 cases per 100,000 individuals, while low- and middle-income countries experience up to 139 cases per 100,000. The prevalence of neurological diseases, therefore, plays a pivotal role in driving the growth of the concussion market.

Product innovation stands out as a prominent trend shaping the landscape of the concussion market. Leading companies in this market are directing their efforts towards developing innovative products to enhance their diagnostic capabilities and maintain a competitive edge. One notable example is TecTraum Inc., a US-based medical device designer, and Nottingham-Spirk Design Associates Inc., a US-based product design firm, who collaborated to introduce pro2cool in May 2022. Recognized as the world's first point-of-care treatment for concussions, pro2cool is a groundbreaking noninvasive hypothermic treatment device. Engineered to alleviate the severity of concussion symptoms, it aims to expedite patients' recovery to their pre-injury baseline. The device achieves this by locally cooling the head and neck, thereby lowering blood temperature before it reaches the brain. Clinical investigations have shown promising results, indicating significant improvements in clinical outcomes when the brain is cooled within days following a concussion.

Major players are embracing strategic partnerships as a proactive approach to raise awareness about the gravity of concussions. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefits and success. An illustrative instance of such collaboration is the partnership between Abbott Laboratories, a US-based medical device company, and the Brain Injury Association of America (BIAA), a US-based national organization. Formed in December 2022, this alliance aims to heighten awareness about the seriousness of concussions and emphasize the importance of seeking care for potential concussions. The coalition, comprising nearly twenty advocacy groups, addresses the alarming fact that more than half of individuals suspecting a concussion fail to seek medical evaluation. This strategic collaboration is positioned to play a crucial role in raising public consciousness about concussion-related issues.

In August 2023, Oxeia Biopharmaceuticals Inc., a clinical-stage biotech company based in the United States, successfully acquired SUN11031, a synthetic human ghrelin compound, from Kinemed Inc., another U.S.-based pharmaceutical research and development firm. The financial details of this transaction were not disclosed. This strategic acquisition by Oxeia Biopharmaceuticals aims to leverage SUN11031, which will be developed under the designation OXE103, as a potential treatment for concussions and acute neurotrauma.

Major companies operating in the concussion market include Pfizer Inc., Novartis AG, Sanofi SA, Abbott Laboratories, Medtronic plc, Viatris Inc., Zydus Lifesciences Ltd., Integra LifeSciences Corporation, Nihon Kohden Corporation, Raumedic AG, Lupin Limited, NeuroPace Inc., Compumedics Limited, NeuroLogica Corporation, Neural Analytics Inc., NovaSignal Corp., Back Bay Life Science Advisors, BrainScope Company Inc., Neuro Kinetics Inc., ImPACT Applications Inc., NanoDx Inc., Neuren Pharmaceuticals Limited, Advanced Brain Monitoring Inc., ElMindA Ltd., NeurOptics Inc., InfraScan Inc., Neuro Assessment Systems Inc., NeuroTrauma Sciences LLC, SyncThink Inc., Oxeia Biopharmaceuticals Inc., Oculogica Inc., Banyan Biomarkers Inc., Emotiv Inc., BioDirection Inc., Neurologic Wellness Institute

North America was the largest region in the concussion market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the concussion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the concussion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The concussion market consists of revenues earned by entities by providing concussion services such as consultations, diagnostic tests, imaging studies, CT scans, MRIs, and specialized diagnostic tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The concussion market also includes sales of medications such as pain relievers, anti-nausea medication, or drugs targeting sleep disturbances or mood disorders. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Concussion Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on concussion market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for concussion ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The concussion market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Concussion Market Characteristics

3. Concussion Market Trends And Strategies

4. Concussion Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Concussion Growth Analysis And Strategic Analysis Framework

6. Concussion Market Segmentation

7. Concussion Market Regional And Country Analysis

8. Asia-Pacific Concussion Market

9. China Concussion Market

10. India Concussion Market

11. Japan Concussion Market

12. Australia Concussion Market

13. Indonesia Concussion Market

14. South Korea Concussion Market

15. Western Europe Concussion Market

16. UK Concussion Market

17. Germany Concussion Market

18. France Concussion Market

19. Italy Concussion Market

20. Spain Concussion Market

21. Eastern Europe Concussion Market

22. Russia Concussion Market

23. North America Concussion Market

24. USA Concussion Market

25. Canada Concussion Market

26. South America Concussion Market

27. Brazil Concussion Market

28. Middle East Concussion Market

29. Africa Concussion Market

30. Concussion Market Competitive Landscape And Company Profiles

31. Concussion Market Other Major And Innovative Companies

32. Global Concussion Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Concussion Market

34. Recent Developments In The Concussion Market

35. Concussion Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기